Open research questions in Head and Neck Cancer Studies
316 unresolved questions extracted from the limitations and future-work sections of 2,379 Head and Neck Cancer Studies papers in our library. Each links back to the study that raised it.
What the literature leaves open
further studies could investigate the application of machine learning techniques in clinical oncology, - research could focus on identifying complex prognostic patterns in high-dimensional data, - studies could explore the use of multivariable models in mortality risk stratification beyond TNM staging alone in OTSCC patients
Development and external validation of a nomogram for overall survival in oral tongue squamous cell carcinoma using machine learning-assisted feature selection · 2026 · DOIThe current prognosis of OTSCC relies heavily on TNM staging, which may not be sufficient to accurately predict patient outcomes. There is a need to maximize the prognostic value of routinely available clinical and histopathological data. The study aims to address this gap by developing a prognostic nomogram using machine learning-assisted feature selection.
Development and external validation of a nomogram for overall survival in oral tongue squamous cell carcinoma using machine learning-assisted feature selection · 2026 · DOIClinical evidence on the effectiveness of 3D exoscopic surgery in OPSCC is limited. There is a need for studies comparing the pathological radicality and surgical margin adequacy of transoral resections using robotic and exoscopic approaches.
Resection margins in transoral oropharyngeal surgery: comparative analysis of robotic and VITOM Eagle–assisted exoscopic approaches · 2026 · DOIFurther research is needed to investigate the association between HPV outcomes and socioeconomic factors, - Further research is needed to investigate the association between HPV outcomes and sexual behaviours
Assessing the Incidence, Persistence and Clearance of Oral HPV Detection Among Metropolitan and Non-Metropolitan Indigenous Australian Adults · 2026 · DOILimited longitudinal evidence on oral HPV among Aboriginal and Torres Strait Islander peoples. Limited understanding of the associations between HPV outcomes and behavioural, sexual health, and socioeconomic factors.
Assessing the Incidence, Persistence and Clearance of Oral HPV Detection Among Metropolitan and Non-Metropolitan Indigenous Australian Adults · 2026 · DOIIn spite of mounting evidence on their impact on survival outcomes, the incorporation of histopathological features, including perineural invasion (PNI) and the worst pattern of invasion, in staging and risk stratification is still lacking.
Survival Trends Associated With Histopathological Risk Factors in Oral Squamous Cell Carcinoma · 2026 · DOIThe strong positive correlation of ALDH1-High score with advanced stage and grade highlights its potential role as a key driver of tumor aggression, warranting further investigation as a prognostic marker.
Correlation Between Prognostic Indicators, HPV Status, and Cancer Stem Cell Markers in a Population of Human Tongue Carcinomas · 2026 · DOIWhile tobacco and alcohol are established risk factors, the role of human papillomavirus (HPV) in oral carcinogenesis remains debated.
Correlation Between Prognostic Indicators, HPV Status, and Cancer Stem Cell Markers in a Population of Human Tongue Carcinomas · 2026 · DOITimeliness after laryngectomy for pathologic T4 (pT4) laryngeal cancer is poorly characterized.
Predictors of Delayed and Omitted Postoperative Radiotherapy After Laryngectomy for pT4 Laryngeal Cancer · 2026 · DOITransoral robotic surgery (TORS) with neck dissection has emerged as an organ-preserving treatment for hypopharyngeal squamous cell carcinoma (HPSCC), but long-term evidence remains limited.
Transoral robotic surgery and neck dissection for hypopharyngeal cancer: long-term prognostic factors and survival outcomes · 2026 · DOIOBJECTIVES: While there are plausible biological explanations for the association between oral health and head and neck cancers (HNC), existing studies have yielded conflicting results.
Oral Health—Head and Neck Cancers: Addressing Confounding Through Negative Control and Quantitative Bias Analyses · 2025 · DOIThe premetastatic niche (PMN), a modified lymph node microenvironment preparing for future metastasis, is poorly understood.
Nonmetastatic Lymph Node Histological Architecture Is Associated With Metastasis, Recurrence, and Survival in Oral Squamous Cell Carcinoma · 2025 · DOIBackground/purpose: South Asia has a high burden of oral cancer (OC); however, delays in diagnosis remain under-researched.
Patient-related factors influencing delays in oral cancer diagnosis: Insights from Pakistan · 2025 · DOIBackground/purpose: Tegafur-uracil (UFUR) is widely prescribed as metronomic adjuvant chemotherapy for oral squamous cell carcinoma (OSCC) in East Asia, though its long-term benefit remains unclear.
Adjuvant metronomic tegafur-uracil is associated with poorer outcomes and unfavorable histopathologic progression in oral squamous cell carcinomas · 2025 · DOICONCLUSIONS: Although a relatively high level of awareness concerning HPV was observed, the gaps in knowledge suggest that further efforts are necessary to educate young adults.
An Assessment of Young Adults’ Awareness and Knowledge Related to the Human Papillomavirus (HPV), Oropharyngeal Cancer, and the HPV Vaccine · 2025 · DOIPost-TORS haemorrhage represents the most severe complication associated with TORS, however currently there is no consensus for managing these patients.
CONCLUSIONS: The significantly increased incidence of lip, oral cavity and pharyngeal cancers in Aboriginal and Torres Strait Islander peoples in Australia is concerning and should be explored.
Lip, oral and oropharyngeal cancer incidence among Aboriginal and Torres Strait Islander Peoples: First report from Australian population‐based cancer registry, 1999–2018 · 2024 · DOIWe suggest that young adults should be considered high-risk for the contraction of oral HPV, although acknowledge that this sample of HE students may not be representative of the wider population.
Risk factors associated with oral Human Papillomavirus (HPV) prevalence within a young adult population · 2024 · DOIDespite this uniqueness, studies that solidly assess the efficacy and cost-effectiveness of oral cancer screening are scanty, and the only large randomized trial undertaken so far shows limited evidence of mortality reduction through population screening.
In patients with oral cancer, the risk factors for local, regional, and distant recurrence according to margin status have not been well established.
The incidence of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is rising in the West, but little is known in Asia.
Changes in the Incidence and Human Papillomavirus-Positive Portion of Oropharyngeal Squamous Cell Carcinoma in Hong Kong · 2024 · DOIA comprehensive report using standardized methods is warranted to characterize the risk and to inform on survivorship strategy.
Further research is needed to investigate the long-term outcomes of VMAT and IMRT in the treatment of tongue cancer. The role of concurrent chemotherapy in combination with VMAT or IMRT should be explored. The development of new treatment strategies and technologies should be investigated to improve the outcomes of tongue cancer patients.
Intensity-Modulated Radiotherapy versus Volumetric Modulated Arc Therapy in Post-operative Carcinoma Tongue: A Systematic Review of Dosimetric Parameters, Treatment Efficiency, and Clinical Outcomes · 2026 · DOIThe delivery of adequate radiation doses to target volumes while minimizing toxicity to surrounding normal tissues remains a clinical challenge. There is a need for a comprehensive comparison of IMRT and VMAT in the post-operative setting for tongue cancer patients.
Intensity-Modulated Radiotherapy versus Volumetric Modulated Arc Therapy in Post-operative Carcinoma Tongue: A Systematic Review of Dosimetric Parameters, Treatment Efficiency, and Clinical Outcomes · 2026 · DOIThe lack of effective hemostatic agents for controlling bleeding during endoscopic nasopharyngeal biopsy. The need for a standardized first-line pharmacologic intervention for nasopharyngeal hemorrhage management. The limited understanding of the efficacy and safety of topical tranexamic acid in patients undergoing endoscopic nasopharyngeal biopsy.
Topical Tranexamic Acid Application to Facilitate Biopsy Acquisition in Endoscopic Nasopharyngeal Biopsy: A Prospective Case Series Analysis · 2026 · DOI
Most-cited papers in Head and Neck Cancer Studies
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer · New England Journal of Medicine · 2010 · 5,786 citations
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck · New England Journal of Medicine · 2016 · 4,619 citations
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck · New England Journal of Medicine · 2006 · 4,400 citations
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer · New England Journal of Medicine · 2008 · 3,189 citations
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study · The Lancet · 2019 · 2,981 citations
- Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck · New England Journal of Medicine · 2004 · 2,825 citations
- Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer · New England Journal of Medicine · 2004 · 2,763 citations
- Global epidemiology of oral and oropharyngeal cancer · Oral Oncology · 2008 · 2,634 citations
- Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer · New England Journal of Medicine · 2003 · 2,618 citations
- Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer · New England Journal of Medicine · 1991 · 2,271 citations
Most recent work
- Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial · The Lancet · 2026
- Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial · BMJ · 2026
- Do Effects of Voice Rehabilitation in Patients Irradiated for Laryngeal Cancer Remain 5 Years Postradiotherapy? · Journal of Voice · 2026
- Global HPV genotype distribution and coinfections in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis · Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology · 2026
- Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials · Journal of Clinical Oncology · 2026
- Long-Term outcomes of induction chemotherapy–guided reduced-dose chemoradiotherapy in poor-risk HPV-Positive oropharyngeal Cancer: Results from the sequential quarterback trials · Oral Oncology · 2026
- Contemporary management of the clinically N0 neck in oral squamous cell carcinoma · Oral Oncology · 2026
- Survival in node-positive early oral squamous cell carcinoma following sentinel lymph node biopsy or elective neck dissection · Oral Oncology · 2026
- Efficacy of radiotherapy to metastatic lesion in de novo metastatic nasopharyngeal carcinoma patients: A multicenter, propensity score matching study · Oral Oncology · 2026
- Tumour microenvironment diversity of HNSCC and the molecular landscape of recurrent disease · Oral Oncology · 2026
Find a gap in your own Head and Neck Cancer Studies sub-topic
This page shows what the Head and Neck Cancer Studies literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →